Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Horizon Therapeutics (HZNP)

Horizon Therapeutics (HZNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,374,292
  • Shares Outstanding, K 220,710
  • Annual Sales, $ 1,300 M
  • Annual Income, $ 573,020 K
  • 60-Month Beta 1.15
  • Price/Sales 9.75
  • Price/Cash Flow 22.74
  • Price/Book 4.59
Trade HZNP with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.03
  • Number of Estimates 6
  • High Estimate 1.15
  • Low Estimate 0.90
  • Prior Year 0.56
  • Growth Rate Est. (year over year) +83.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.41 +18.54%
on 12/21/20
81.18 -3.03%
on 01/12/21
+1.62 (+2.10%)
since 12/15/20
3-Month
66.41 +18.54%
on 12/21/20
82.34 -4.40%
on 11/04/20
-0.61 (-0.77%)
since 10/15/20
52-Week
23.81 +230.62%
on 03/18/20
86.67 -9.17%
on 10/09/20
+40.98 (+108.59%)
since 01/15/20

Most Recent Stories

More News
Horizon (HZNP) Provides Preliminary 2020 Financial Results

Horizon (HZNP) provides 2020 preliminary financial results and updates on its key drugs.

ALKS : 22.37 (+1.68%)
HALO : 47.43 (+0.81%)
HZNP : 78.72 (-0.24%)
ARPO : 1.2000 (-1.64%)
Horizon Therapeutics plc Provides Preliminary 2020 Financial Results, Exceeding Full-Year 2020 Net Sales and Adjusted EBITDA Guidance; Provides Update on TEPEZZA(R) (teprotumumab-trbw) Supply and New KRYSTEXXA(R) (pegloticase injection) Trials

Horizon Therapeutics plc (Nasdaq: HZNP) today announced updates on its 2020 financial results, TEPEZZA supply and new KRYSTEXXA trials.

JPM : 138.64 (-1.79%)
HZNP : 78.72 (-0.24%)
New Strong Sell Stocks for January 6th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

HZNP : 78.72 (-0.24%)
ALK : 53.65 (-3.19%)
GBT : 49.92 (+0.30%)
ICHR : 39.61 (-2.85%)
KL : 39.32 (-2.36%)
Look for Shares of Horizon Pharma P to Potentially Pullback after Yesterday's 3.21% Rise

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $70.40 to a high of $72.37. Yesterday, the shares gained 3.2%, which took the trading range above the 3-day high...

HZNP : 78.72 (-0.24%)
Horizon Therapeutics plc to Present at the 39th Annual J.P. Morgan Healthcare Conference

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the 39th Annual J.P. Morgan Healthcare Conference. Tim Walbert, chairman, president and chief executive officer,...

JPM : 138.64 (-1.79%)
HZNP : 78.72 (-0.24%)
Enzymes Global Market Report 2020-30: COVID-19 Growth and Change

Reportlinker.com announces the release of the report "Enzymes Global Market Report 2020-30: COVID-19 Growth and Change" - https://www.reportlinker.com/p05998717/?utm_source=GNW

ABBV : 110.52 (-0.99%)
ALXN : 156.70 (+0.03%)
AGN : 193.02 (+0.02%)
HZNP : 78.72 (-0.24%)
PFE : 36.70 (-0.14%)
Horizon Therapeutics plc Announces Short-Term TEPEZZA(R) (teprotumumab-trbw) Supply Disruption Due to Government-Mandated (Operation Warp Speed) COVID-19 Vaccine Production

Horizon Therapeutics plc (Nasdaq: HZNP) announced that it expects a short-term disruption in TEPEZZA (teprotumumab-trbw) supply as a result of recent government-mandated COVID-19 vaccine production orders...

HZNP : 78.72 (-0.24%)
Horizon Pharma P Rises 1.78% on Heavy Volume: Watch For Potential Pullback

Horizon Pharma P (NASDAQ:HZNP) traded in a range yesterday that spanned from a low of $73.55 to a high of $75.55. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high...

HZNP : 78.72 (-0.24%)
Horizon Therapeutics plc Provides $1 Million in Scholarships to Help Economically Disadvantaged Students and Students of Color Further Their Liberal Arts and Health Professions Education

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has provided $500,000 in scholarships to Lake Forest College and created a $500,000 Horizon Therapeutics Endowed Scholarship Fund at Howard...

HZNP : 78.72 (-0.24%)
Horizon Therapeutics (HZNP) Down 6.7% Since Last Earnings Report: Can It Rebound?

Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HZNP : 78.72 (-0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. ...

See More

Key Turning Points

3rd Resistance Point 82.28
2nd Resistance Point 80.80
1st Resistance Point 79.76
Last Price 78.72
1st Support Level 77.24
2nd Support Level 75.76
3rd Support Level 74.72

See More

52-Week High 86.67
Last Price 78.72
Fibonacci 61.8% 62.66
Fibonacci 50% 55.24
Fibonacci 38.2% 47.82
52-Week Low 23.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar